Atrial fibrillation (AF) is a relatively frequent complication after autologous stem cell transplantation in patients with multiple myeloma, one that’s associated with an increased risk of mortality, ...
Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging survival. Patients are living years longer, thanks to novel combination therapies ...
A blood and marrow transplant (BMT) is a treatment used for certain cancer types that works by resetting the body’s ability to make healthy blood cells. It does this by replacing damaged or destroyed ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...
Mansi Shah, MD, discusses the role of stem cell transplant in multiple myeloma (MM) and the logistical barriers to wider adoption of bispecific therapies. While chimeric antigen receptor (CAR) T-cell ...
Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...
Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't ...
Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibody Use in Earlier Lines of Treatment of Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma Treatment of multiple myeloma ...
Results showed the minimal residual disease negativity rate was 52.3% in the D-VRd arm vs 34.8% in the VRd arm. The Food and Drug Administration (FDA) has approved Darzalex Faspro ® (daratumumab and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results